These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8229066)

  • 1. Proto-oncogene c-fos induction in thiamine-deficient encephalopathy. Protective effects of nicardipine on pyrithiamine-induced lesions.
    Munujos P; Vendrell M; Ferrer I
    J Neurol Sci; 1993 Sep; 118(2):175-80. PubMed ID: 8229066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy. 2. alpha-Ketoglutarate dehydrogenase.
    Butterworth RF; Giguère JF; Besnard AM
    Neurochem Res; 1986 Apr; 11(4):567-77. PubMed ID: 3724963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain endothelial dysfunction following pyrithiamine induced thiamine deficiency in the rat.
    Sarkar S; Liachenko S; Paule MG; Bowyer J; Hanig JP
    Neurotoxicology; 2016 Dec; 57():298-309. PubMed ID: 27984051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causality of parenchymal and vascular changes in rats with experimental thiamine deficiency encephalopathy.
    Chen Q; Okada S; Okeda R
    Pathol Int; 1997 Nov; 47(11):748-56. PubMed ID: 9413033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrithiamine-induced thiamine deficiency alters proliferation and neurogenesis in both neurogenic and vulnerable areas of the rat brain.
    Hazell AS; Wang D; Oanea R; Sun S; Aghourian M; Yong JJ
    Metab Brain Dis; 2014 Mar; 29(1):145-52. PubMed ID: 24078061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions.
    Zhang SX; Weilersbacher GS; Henderson SW; Corso T; Olney JW; Langlais PJ
    J Neuropathol Exp Neurol; 1995 Mar; 54(2):255-67. PubMed ID: 7876893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: an in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy.
    Pannunzio P; Hazell AS; Pannunzio M; Rao KV; Butterworth RF
    J Neurosci Res; 2000 Oct; 62(2):286-92. PubMed ID: 11020221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging potentiates the acute and chronic neurological symptoms of pyrithiamine-induced thiamine deficiency in the rodent.
    Pitkin SR; Savage LM
    Behav Brain Res; 2001 Mar; 119(2):167-77. PubMed ID: 11165332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrithiamine-induced acute thiamine-deficient encephalopathy in the mouse.
    Watanabe I
    Exp Mol Pathol; 1978 Jun; 28(3):381-94. PubMed ID: 648625
    [No Abstract]   [Full Text] [Related]  

  • 10. Histamine-mediated neuronal death in a rat model of Wernicke's encephalopathy.
    Langlais PJ; Zhang SX; Weilersbacher G; Hough LB; Barke KE
    J Neurosci Res; 1994 Aug; 38(5):565-74. PubMed ID: 7529327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective down-regulation of the astrocyte glutamate transporters GLT-1 and GLAST within the medial thalamus in experimental Wernicke's encephalopathy.
    Hazell AS; Rao KV; Danbolt NC; Pow DV; Butterworth RF
    J Neurochem; 2001 Aug; 78(3):560-8. PubMed ID: 11483659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MK-801 prevents brain lesions and delayed-nonmatching-to-sample deficits produced by pyrithiamine-induced encephalopathy in rats.
    Robinson JK; Mair RG
    Behav Neurosci; 1992 Aug; 106(4):623-33. PubMed ID: 1386989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro proton NMR spectroscopic studies of thiamine-deficient rat brains.
    Lee H; Holburn GE; Price RR
    J Magn Reson Imaging; 2001 Feb; 13(2):163-6. PubMed ID: 11169820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between in vivo neuroimaging and postmortem brain cytokine markers in a rodent model of Wernicke's encephalopathy.
    Zahr NM; Alt C; Mayer D; Rohlfing T; Manning-Bog A; Luong R; Sullivan EV; Pfefferbaum A
    Exp Neurol; 2014 Nov; 261():109-19. PubMed ID: 24973622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the role of NMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke encephalopathy.
    Todd KG; Butterworth RF
    Exp Neurol; 1998 Jan; 149(1):130-8. PubMed ID: 9454622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional alterations of thiamine phosphate esters and of thiamine diphosphate-dependent enzymes in relation to function in experimental Wernicke's encephalopathy.
    Héroux M; Butterworth RF
    Neurochem Res; 1995 Jan; 20(1):87-93. PubMed ID: 7739764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo localized proton NMR spectroscopy of thiamine-deficient rat brain.
    Lee H; Tarter J; Holburn GE; Price RR; Weinstein DD; Martin PR
    Magn Reson Med; 1995 Sep; 34(3):313-8. PubMed ID: 7500868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and resolution of brain lesions caused by pyrithiamine- and dietary-induced thiamine deficiency and alcohol exposure in the alcohol-preferring rat: a longitudinal magnetic resonance imaging and spectroscopy study.
    Pfefferbaum A; Adalsteinsson E; Bell RL; Sullivan EV
    Neuropsychopharmacology; 2007 May; 32(5):1159-77. PubMed ID: 16723995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of brain histamine produces regionally selective protection against thiamine deficiency-induced lesions in the rat.
    Langlais PJ; McRee RC; Nalwalk JA; Hough LB
    Metab Brain Dis; 2002 Sep; 17(3):199-210. PubMed ID: 12322789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of neuronal cell death in Wernicke's encephalopathy.
    Hazell AS; Todd KG; Butterworth RF
    Metab Brain Dis; 1998 Jun; 13(2):97-122. PubMed ID: 9699919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.